American Financial Group’s Biogen BIIB Stock Holding History

American Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,500	Closed	-$979K	–	91
2021 Q1	$979K	Sell	3,500 -3,500	-50%	-$944K	0.16%	67
2020 Q4	$1.71M	Hold	7,000	–	–	0.22%	70
2020 Q3	$1.99M	Hold	7,000	–	–	0.27%	65
2020 Q2	$1.87M	Hold	7,000	–	–	0.25%	73
2020 Q1	$2.21M	Hold	7,000	–	–	0.26%	73
2019 Q4	$2.08M	Hold	7,000	–	–	0.18%	78
2019 Q3	$1.63M	Hold	7,000	–	–	0.13%	89
2019 Q2	$1.64M	Hold	7,000	–	–	0.13%	90
2019 Q1	$1.65M	Hold	7,000	–	–	0.15%	90
2018 Q4	$2.11M	Hold	7,000	–	–	0.2%	86
2018 Q3	$2.47M	Hold	7,000	–	–	0.24%	75
2018 Q2	$2.03M	Hold	7,000	–	–	0.19%	83
2018 Q1	$1.92M	Hold	7,000	–	–	0.18%	88
2017 Q4	$2.23M	Hold	7,000	–	–	0.24%	76
2017 Q3	$2.19M	Hold	7,000	–	–	0.23%	75
2017 Q2	$1.9M	Hold	7,000	–	–	0.18%	82
2017 Q1	$1.91M	Hold	7,000	–	–	0.18%	82
2016 Q4	$1.99M	Hold	7,000	–	–	0.19%	82
2016 Q3	$2.19M	Hold	7,000	–	–	0.16%	84
2016 Q2	$1.69M	Hold	7,000	–	–	0.13%	86
2016 Q1	$1.82M	Hold	7,000	–	–	0.14%	88
2015 Q4	$2.14M	Hold	7,000	–	–	0.16%	85
2015 Q3	$2.04M	Buy	+7,000	New	+$2.31M	0.15%	93

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

American Financial Group's BIIB Position: Q2 2021 in Review

American Financial Group sold out of Biogen (BIIB) in Q2 2021, closing a stake of 3,500 shares — an estimated $979K sold.

American Financial Group first reported a position in BIIB in Q3 2015 and held it in 23 quarters. The position peaked at $2.47M in Q3 2018. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

American Financial Group reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
American Financial Group sold 3,500 Biogen shares in Q2 2021, an estimated $979K.
American Financial Group first reported a position in Biogen in Q3 2015 and held it in 23 quarters.
American Financial Group's Biogen position peaked at $2.47M in Q3 2018.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on American Financial Group's 13F filing for Q2 2021, filed 6 Aug 2021.